Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Equity

Summit Therapeutics (SMMT) Return on Assets (2022 - 2025)

Summit Therapeutics' Return on Assets history spans 4 years, with the latest figure at 0.22% for Q3 2025.

  • For Q3 2025, Return on Assets rose 26.0% year-over-year to 0.22%; the TTM value through Sep 2025 reached 0.22%, up 26.0%, while the annual FY2024 figure was 0.74%, 68.0% up from the prior year.
  • Return on Assets reached 0.22% in Q3 2025 per SMMT's latest filing, up from 0.36% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.09% in Q4 2022 to a low of 2.89% in Q4 2023.
  • Average Return on Assets over 4 years is 0.97%, with a median of 0.5% recorded in 2024.
  • Peak YoY movement for Return on Assets: tumbled -280bps in 2023, then surged 239bps in 2024.
  • A 4-year view of Return on Assets shows it stood at 0.09% in 2022, then crashed by -3084bps to 2.89% in 2023, then surged by 83bps to 0.5% in 2024, then surged by 55bps to 0.22% in 2025.
  • Per Business Quant, the three most recent readings for SMMT's Return on Assets are 0.22% (Q3 2025), 0.36% (Q2 2025), and 0.46% (Q1 2025).